ARTICLE | Company News
FDA approves Tap's Spectracef
September 12, 2001 7:00 AM UTC
The FDA granted marketing approval for Spectracef cefditoren pivoxil from Tap Pharmaceutical (Lake Forest, Ill.) to treat acute exacerbations of chronic bronchitis, pharyngitis/tonsillitis and uncompl...